Biotech Values

[BTH]

I tend to agree with the statement that IPH.PA Kir is more valuable than any IO asset CLDX has at this point (I still think CLDX has a bunch of IO junk, despite taking 600% or so on it last year).

Whether CLDX deserves a broken out $1B value on CDX-1127 is anyone's guess, but, IF CLDX rightfully deserves that value for 1127, I would think IPH.PA deserves at least that valuation, perhaps even much much more over time.